Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs.

Tannenbaum CS, Rayman PA, Pavicic PG, Kim JS, Wei W, Polefko A, Wallace W, Rini BI, Morris-Stiff G, Allende DS, Hamilton T, Finke JH, Diaz-Montero CM.

Cancer Immunol Res. 2019 Oct;7(10):1687-1699. doi: 10.1158/2326-6066.CIR-18-0578. Epub 2019 Aug 22.

PMID:
31439615
2.

Structure-Function Analysis of the Mcl-1 Protein Identifies a Novel Senescence-regulating Domain.

Demelash A, Pfannenstiel LW, Tannenbaum CS, Li X, Kalady MF, DeVecchio J, Gastman BR.

J Biol Chem. 2015 Sep 4;290(36):21962-75. doi: 10.1074/jbc.M115.663898. Epub 2015 Jul 23.

3.

Elevated levels of select gangliosides in T cells from renal cell carcinoma patients is associated with T cell dysfunction.

Biswas S, Biswas K, Richmond A, Ko J, Ghosh S, Simmons M, Rayman P, Rini B, Gill I, Tannenbaum CS, Finke JH.

J Immunol. 2009 Oct 15;183(8):5050-8. doi: 10.4049/jimmunol.0900259.

4.

GD3, an overexpressed tumor-derived ganglioside, mediates the apoptosis of activated but not resting T cells.

Sa G, Das T, Moon C, Hilston CM, Rayman PA, Rini BI, Tannenbaum CS, Finke JH.

Cancer Res. 2009 Apr 1;69(7):3095-104. doi: 10.1158/0008-5472.CAN-08-3776. Epub 2009 Mar 10.

5.

Renal cell carcinoma tumors induce T cell apoptosis through receptor-dependent and receptor-independent pathways.

Das T, Sa G, Paszkiewicz-Kozik E, Hilston C, Molto L, Rayman P, Kudo D, Biswas K, Bukowski RM, Finke JH, Tannenbaum CS.

J Immunol. 2008 Apr 1;180(7):4687-96.

6.

TNF-alpha induction of GM2 expression on renal cell carcinomas promotes T cell dysfunction.

Raval G, Biswas S, Rayman P, Biswas K, Sa G, Ghosh S, Thornton M, Hilston C, Das T, Bukowski R, Finke J, Tannenbaum CS.

J Immunol. 2007 May 15;178(10):6642-52.

7.

CXC chemokine ligand 9/monokine induced by IFN-gamma production by tumor cells is critical for T cell-mediated suppression of cutaneous tumors.

Gorbachev AV, Kobayashi H, Kudo D, Tannenbaum CS, Finke JH, Shu S, Farber JM, Fairchild RL.

J Immunol. 2007 Feb 15;178(4):2278-86.

8.

Tumor-induced oxidative stress perturbs nuclear factor-kappaB activity-augmenting tumor necrosis factor-alpha-mediated T-cell death: protection by curcumin.

Bhattacharyya S, Mandal D, Sen GS, Pal S, Banerjee S, Lahiry L, Finke JH, Tannenbaum CS, Das T, Sa G.

Cancer Res. 2007 Jan 1;67(1):362-70.

9.

GM2 expression in renal cell carcinoma: potential role in tumor-induced T-cell dysfunction.

Biswas K, Richmond A, Rayman P, Biswas S, Thornton M, Sa G, Das T, Zhang R, Chahlavi A, Tannenbaum CS, Novick A, Bukowski R, Finke JH.

Cancer Res. 2006 Jul 1;66(13):6816-25.

10.

Degradation of NF-kappa B in T cells by gangliosides expressed on renal cell carcinomas.

Thornton MV, Kudo D, Rayman P, Horton C, Molto L, Cathcart MK, Ng C, Paszkiewicz-Kozik E, Bukowski R, Derweesh I, Tannenbaum CS, Finke JH.

J Immunol. 2004 Mar 15;172(6):3480-90.

11.

Mechanisms of immune dysfunction in renal cell carcinoma.

Derweesh IH, Tannenbaum CS, Rayman PA, Finke JH.

Cancer Treat Res. 2003;116:29-51. Review. No abstract available.

PMID:
14650824
12.

Immunotherapy with interleukin-10 depends on the CXC chemokines inducible protein-10 and monokine induced by IFN-gamma.

Dorsey R, Kundu N, Yang Q, Tannenbaum CS, Sun H, Hamilton TA, Fulton AM.

Cancer Res. 2002 May 1;62(9):2606-10.

13.

Mechanisms of immune evasion by renal cell carcinoma: tumor-induced T-lymphocyte apoptosis and NFkappaB suppression.

Ng CS, Novick AC, Tannenbaum CS, Bukowski RM, Finke JH.

Urology. 2002 Jan;59(1):9-14. Review. No abstract available.

PMID:
11796271
14.

Tumor-induced sensitivity to apoptosis in T cells from patients with renal cell carcinoma: role of nuclear factor-kappaB suppression.

Finke JH, Rayman P, George R, Tannenbaum CS, Kolenko V, Uzzo R, Novick AC, Bukowski RM.

Clin Cancer Res. 2001 Mar;7(3 Suppl):940s-946s.

PMID:
11300495
15.

Immune-inflammatory mechanisms in IFNgamma-mediated anti-tumor activity.

Tannenbaum CS, Hamilton TA.

Semin Cancer Biol. 2000 Apr;10(2):113-23. Review.

PMID:
10936062
16.

Interferon-gamma and CXC chemokine induction by interleukin 12 in renal cell carcinoma.

Bukowski RM, Rayman P, Molto L, Tannenbaum CS, Olencki T, Peereboom D, Tubbs R, McLain D, Budd GT, Griffin T, Novick A, Hamilton TA, Finke J.

Clin Cancer Res. 1999 Oct;5(10):2780-9.

17.

The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor.

Tannenbaum CS, Tubbs R, Armstrong D, Finke JH, Bukowski RM, Hamilton TA.

J Immunol. 1998 Jul 15;161(2):927-32.

18.

Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12.

Tannenbaum CS, Wicker N, Armstrong D, Tubbs R, Finke J, Bukowski RM, Hamilton TA.

J Immunol. 1996 Jan 15;156(2):693-9.

PMID:
8543822
19.

Chemokine gene expression in the murine renal cell carcinoma, RENCA, following treatment in vivo with interferon-alpha and interleukin-2.

Sonouchi K, Hamilton TA, Tannenbaum CS, Tubbs RR, Bukowski R, Finke JH.

Am J Pathol. 1994 Apr;144(4):747-55.

20.

Transmembrane and intracellular signaling events in lipopolysaccharide-stimulated macrophages.

Hamilton TA, Ohmori Y, Tebo JM, Narumi S, Tannenbaum CS.

Immunol Ser. 1994;60:83-97. Review. No abstract available.

PMID:
8251597
21.
22.

Synergistic cooperation between T cell lymphokines for induction of the nitric oxide synthase gene in murine peritoneal macrophages.

Deng W, Thiel B, Tannenbaum CS, Hamilton TA, Stuehr DJ.

J Immunol. 1993 Jul 1;151(1):322-9.

PMID:
7686939
24.

Tissue-specific expression of murine IP-10 mRNA following systemic treatment with interferon gamma.

Narumi S, Wyner LM, Stoler MH, Tannenbaum CS, Hamilton TA.

J Leukoc Biol. 1992 Jul;52(1):27-33.

PMID:
1640172
25.
26.

Lipopolysaccharide induces competence genes JE and KC in Balb/C 3T3 cells.

Tannenbaum CS, Major JA, Poptic EJ, DiCorleto PE, Hamilton TA.

J Cell Physiol. 1990 Jul;144(1):77-83.

PMID:
2114413
27.
28.

Lipopolysaccharide-inducible macrophage early genes are induced in Balb/c 3T3 cells by platelet-derived growth factor.

Tannenbaum CS, Major J, Poptic E, DiCorleto PE, Hamilton TA.

J Biol Chem. 1989 Mar 5;264(7):4052-7.

30.

Role of the maleyl-albumin receptor in activation of murine peritoneal macrophages in vitro.

Haberland ME, Tannenbaum CS, Williams RE, Adams DO, Hamilton TA.

J Immunol. 1989 Feb 1;142(3):855-62.

PMID:
2536414
31.

Characterization of lipopolysaccharide-induced macrophage gene expression.

Tannenbaum CS, Koerner TJ, Jansen MM, Hamilton TA.

J Immunol. 1988 May 15;140(10):3640-5.

PMID:
2452194
32.

The early competence genes JE and KC are differentially regulated in murine peritoneal macrophages in response to lipopolysaccharide.

Koerner TJ, Hamilton TA, Introna M, Tannenbaum CS, Bast RC Jr, Adams DO.

Biochem Biophys Res Commun. 1987 Dec 31;149(3):969-74.

PMID:
3426621
33.

Differential protein synthesis by murine peritoneal macrophages elicited by various stimuli.

Tannenbaum CS, Nurmi-McKernan L, Largen MT.

J Leukoc Biol. 1987 Jun;41(6):527-38.

PMID:
3496410
34.

The effect of LPS on expression of the early "competence" genes JE and KC in murine peritoneal macrophages.

Introna M, Bast RC Jr, Tannenbaum CS, Hamilton TA, Adams DO.

J Immunol. 1987 Jun 1;138(11):3891-6.

PMID:
3108379
35.

LPS regulation of specific protein synthesis in murine peritoneal macrophages.

Largen MT, Tannenbaum CS.

J Immunol. 1986 Feb 1;136(3):988-93.

PMID:
3484502
36.

Inability of purified Pseudomonas aeruginosa exopolysaccharide to bind selected antibiotics.

Tannenbaum CS, Hastie AT, Higgins ML, Kueppers F, Weinbaum G.

Antimicrob Agents Chemother. 1984 Jun;25(6):673-5.

37.

Protease production by Pseudomonas aeruginosa isolates from patients with cystic fibrosis.

Hastie AT, Hingley ST, Kueppers F, Higgins ML, Tannenbaum CS, Weinbaum G.

Infect Immun. 1983 May;40(2):506-13.

38.

Acuta glaucoma after general surgery.

WANG BC, TANNENBAUM CS, ROBERTAZZI RW.

JAMA. 1961 Jul 15;177:108-10. No abstract available.

PMID:
13783028
39.

The relation of concomitant disease to the occurrence and management of trauma.

TANNENBAUM CS.

Am J Surg. 1958 Jun;95(6):897-907. No abstract available.

PMID:
13533690

Supplemental Content

Loading ...
Support Center